Publikationen
Wyatt KD, Kohorst MA, Coon LM, Hurley RM, van Dorland HA, Arndt CAS
Hereditary Thrombotic Thrombocytopenic Purpura in a 9-Month Old: Diagnosing and Managing an Ultra-rare Disorder
J Pediatr Hematol Oncol. 2020; doi: 10.1097/MPH.0000000000001830
Borogovac A, Tarasco E, Kremer Hovinga JA, George JN
Hypertension in patients with hereditary thrombotic thrombocytopenic purpura.
eJHaem. 2020;DOI:10.1002/jha2.29
Tarasco E, Aebi-Huber I, Kremer Hovinga JA
Die erbliche Form der thrombotisch trombozytopenischen Purpura (TTP) - selten, aber bei Schwangerschaftskomplikationen zu bedenken!
Kremer Hovinga JA, George JN
Hereditary Thrombotic Thrombocytopenic Purpura.
N Engl J Med. 2019;381(17):1653-1662
van Dorland HA, Taleghani MM, Sakai K, Friedman KD, George JN, Hrachovinova I, Knöbl PN, von Krogh AS, Schneppenheim R, Aebi-Huber I, Bütikofer L, Largiadèr CR, Cermakova Z, Kokame K, Miyata T, Yagi H, Terrell DR, Vesely SK, Matsumoto M, Lämmle B, Fujimura Y, Kremer Hovinga JA; Hereditary TTP Registry
The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017.
Haematologica. 2019;104(10):2107-2115
Kremer Hovinga JA, Heeb SR, Skowronska M, Schaller M
Pathophysiology of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
J Thromb Haemost. 2018;16(4):618-629
Scully M, Knöbl P, Kentouche K, Rice L, Windyga J, Schneppenheim R, Kremer Hovinga JA, Kajiwara M, Fujimura Y, Maggiore C, Doralt J, Hibbard C, Martell L, Ewenstein B
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.
Blood. 2017;130(19): 2055-2063
Kremer Hovinga JA, Coppo P, Lämmle B, Moake JL, Miyata T, Vanhoorelbeke K
Thrombotic thrombocytopenic purpura.
Nat Rev Dis Primers. 2017;3:17020
Von Krogh A-S, Quist-Paulsen P, Waage A, Langseth ØO, Thorstensen K, Brudevold R, Tjønnfjord GE, Largiadèr CR, Lämmle B, Kremer Hovinga JA
High prevalence of hereditary thrombotic thrombocytopenic purpura in Central Norway: from clinical observation to evidence.
J Thromb Haemost. 2016;14(1):73-82
Von Krogh A-S, Kremer Hovinga JA, Romundstad PR, Roten LT, Lämmle B, Waage A, Quist-Paulsen P
ADAMTS13 gene variants and function in women with preeclampsia: a population-based nested case-control study from the HUNT study.
Von Auer C, von Krogh A-S, Kremer Hovinga JA , Lämmle B
Current insights into thrombotic microangiopathies: Thrombotic thrombocytopenic purpura and pregnancy.
Thromb Res. 2015;135(Suppl. 1):S30–S33
Raval JS, Padmanabhan A, Kremer Hovinga JA, Kiss JE
Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpura.
Falter T, Kremer Hovinga JA, Lackner K, Füllemann H-G, Lämmle B, Scharrer I
Late onset and pregnancy-induced congenital thrombotic thrombocytopenic purpura.
Haemostaseologie. 2014;34:244–24
Von Krogh A-S, Kremer Hovinga JA, Tjønnfjord GE, Ringen IM, Lämmle B, Waage A, Quist-Paulsen P
The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications.
Thromb Haemost. 2014;111:1180–1183
Knöbl P
Inherited and acquired thrombotic thrombocytopenic purpura (TTP) in adults.
Semin Thromb Hemost. 2014;40:493-502
Bennett M, Chubar Y, Gavish I, Aviv A, Stemer G, Chap-Marshak D
Experiences in a Family With the Upshaw-Schulman Syndrome Over a 44-Year Period.
Clin Appl Thromb Hemost. 2014;20:296-303
Rank CU, Kremer Hovinga JA, Taleghani MM, Lämmle B, Gøtze JP, Nielsen OJ
Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 gene.
Eur J Haematol. 2014;92:168-71
Knöbl PN
Treatment of thrombotic microangiopathy with a focus on new treatment options.
Haemostaseologie. 2013;33:149-59
Kentouche K, Voigt A, Schleussner E, Schneppenheim R, Budde U, Beck JF, Stefanska-Windyga E, Windyga J
Pregnancy in Upshaw-Schulman syndrome.
Haemostaseologie. 2013;29;33:144-8
Mansouri Taleghani M, von Krogh A-S, Fujimura Y, George JN, Hrachovinova I, Knöbl PN, Quist-Paulsen P, Schneppenheim R, Lämmle B, Kremer Hovinga JA
Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman syndrome) and the hereditary TTP registry.
Haemostaseologie. 2013;33:138–143
Deal T, Kremer Hovinga JA, Marques MB, Adamski J
Novel ADAMTS13 Mutations in an Obstetric Patient with Upshaw-Schulman Syndrome.
Kremer Hovinga JA, Lämmle B
ADAMTS13: Its role in pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura.